Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

10x Genomics, Inc. Class A Common Stock | TXG

AI Analysis of 10x Genomics, Inc. Class A Common Stock

10x Genomics is up a bit on the day, funds flowing in kept the price up 2.70% since yesterday.

Currently TXG isn't at a clear support/resistance line that seems tradable. But let's also consider momentum! 10x Genomics has had a nice run over the last year and provided good returns to shareholders. Over the previous year, the asset has grown 378.07 percent which isn't too bad. TXG might find some support at the 15.71 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2026-07-23

Companies with the highest correlation to 10x Genomics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
ADPT | Adaptive Biotechnologies 1.17-0.202.8314.2383.8267.37106.915439.5522.0940.51-1153.12-20925.96007.83993
TWST | Twist Bioscience Corporat1.09-4.2614.9851.02112.45180.57415.4352129.08139.3299.99-2004.51-19916.930023.3961
GH | Guardant Health, Inc. Com1.092.786.7913.9531.6662.83186.9735107.4946.9192.93-2314.24-29121.87005.7115

Top 3 correlating companies

See full charts for all peers

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-